APA (7th ed.) Citation

AE, S., VA, G., NS, S., ES, D., SI, L., LI, R., . . . AL, G. (2024). New conjugates based on N4-hydroxycytidine with more potent antiviral efficacy in vitro than EIDD-2801 against SARS-CoV-2 and other human coronaviruses. Antiviral research, 225, 105871. https://doi.org/10.1016/j.antiviral.2024.105871

Chicago Style (17th ed.) Citation

AE, Siniavin, et al. "New Conjugates Based on N4-hydroxycytidine with More Potent Antiviral Efficacy in Vitro than EIDD-2801 Against SARS-CoV-2 and Other Human Coronaviruses." Antiviral Research 225 (2024): 105871. https://doi.org/10.1016/j.antiviral.2024.105871.

MLA (9th ed.) Citation

AE, Siniavin, et al. "New Conjugates Based on N4-hydroxycytidine with More Potent Antiviral Efficacy in Vitro than EIDD-2801 Against SARS-CoV-2 and Other Human Coronaviruses." Antiviral Research, vol. 225, 2024, p. 105871, https://doi.org/10.1016/j.antiviral.2024.105871.